HARTFORD: Researchers at UConn Health have found blood pressure to be a reliable predictor of the progression of what’s known as “white matter disease,” or small-vessel disease of the brain, which impacts the decline in cognitive function, mobility, and balance associated with aging. And they Read More »

CHICAGO: Advancements in drug discovery for neurodegenerative diseases could be boosted by greater cooperation between pharma companies and small research programs, says GlobalData.

Kyle S Nicholson, GlobalData’s analyst covering neurology, claims evolving ideas are constantly needed in the field that covers Parkinson’s and Alzheimer’s disease… Read More »

CHICAGO: Kyle S. Nicholson, GlobalData’s analyst covering neurology stated that although it is essential that larger and smaller players within the pharma industry collaborate to facilitate progress in Alzheimer’s and Parkinson’s drug development, public funding must be provided to reduce the risks involved from a Read More »

NEW YORK: A new study has determined that brain training and regular exercise, combined with a healthy diet, can significantly slow mental decline in elderly patients at risk for dementia.

Scientists at the Karolinska Institute in Stockholm conducting a study found that two years of Read More »